Dr. Neil Agrawal, MD

Dr. Agrawal practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Agrawal's NPI, 1902935729, was assigned on March 5, 2007. Dr. Agrawal holds Oklahoma license 28267.

Dr. Agrawal's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Agrawal's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Agrawal is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. Agrawal to 3 more hospitals, 6 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Agrawal is licensed in Oklahoma.

CMS data shows 3,933 Medicare services from Dr. Agrawal across 25 procedure codes in 2024, for 2,408 Medicare patients. Medicare paid $118,710 for them.

CMS counts 2,408 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 75 to 84, with 916 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 71, with 52% women.

In 2024, Dr. Agrawal wrote 2,162 Medicare Part D claims for 411 patients. 74% of them were for generic drugs. CMS names the drug for 1,972 of them, across 31 drugs with 11 or more claims each, at $565,947 in total drug cost. In 2023, CMS named 2,889 claims across 35 drugs.

Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 261 general payments to Dr. Agrawal from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $31,331.